Clinical trial
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
NCT06466733 is registered in ClinicalTrials.gov with Juan M. Ramos Acevedo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
- Lead sponsor
- Juan M. Ramos Acevedo
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 31, 2025
- Completion date
- July 31, 2032
- Enrollment
- 658 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
chronic subdural hematoma